Switzerland announced last week that it would not administer the Oxford/AstraZeneca COVID-19 vaccine because the data “available and evaluated to date [is] not yet sufficient,” the country’s health agency said.
The Financial Times reported there have been concerns about the effectiveness of the shot with people above 65, and countries such as Sweden and Germany have advised against its use in the older population. The paper said the U.K. has already rolled out the vaccine, and its government said it is safe for those over 65.
Bern has approved the Pfizer/BioNTech and Moderna vaccines. The FT reported that the Swiss are apprehensive about getting the vaccine, with about one-third saying they would refuse the jab, the report said.
